Literature DB >> 10818118

Haematopoietic cancer and medical history: a multicentre case control study.

P Vineis1, P Crosignani, C Sacerdote, A Fontana, G Masala, L Miligi, O Nanni, V Ramazzotti, S Rodella, E Stagnaro, R Tumino, C Viganò, C Vindigni, A S Costantini.   

Abstract

BACKGROUND: Viruses (such as Epstein-Barr virus) and pathological conditions (mainly involving immunosuppression) have been shown to increase the risk of haematolymphopoietic malignancies. Other associations (diabetes, tonsillectomy, autoimmune diseases) have been inconsistently reported.
METHODS: The association between different haematolymphopoietic malignancies (lymphomas, myelomas and leukaemias) and the previous medical history has been studied in a population-based case-control investigation conducted in Italy, based on face to face interviews to 2669 cases and 1718 population controls (refusal rates 10% and 19%, respectively). Controls were a random sample of the general population.
RESULTS: Previous findings were confirmed concerning the association between non-Hodgkin's lymphoma (NHL) and lupus erythematosus (odds ratio, OR=8.4; 95% CI 1. 6, 45), tuberculosis (OR=1.6; 1.05, 2.5) and hepatitis (1.8; 1.4, 2. 3). An association was found also between NHL and maternal (OR=2.8; 1.1, 6.9) or paternal tuberculosis (OR=1.7; 0.7, 3.9). Odds ratios of 4.0 (1.4, 11.8) and 4.4 (1.1, 6.6) were detected for the association between NHL and Hodgkin's disease, respectively, and previous infectious mononucleosis, but recall bias cannot be ruled out. No association was found with diabetes, tonsillectomy and adenoidectomy. An association with malaria at young age and "low grade" lymphatic malignancies is suggested. One interesting finding was the observation of four cases of poliomyelitis among NHL patients, one among Hodgkin's disease and one among myeloid leukaemia patients, compared with none among the controls (Fisher's exact test for NHL and Hodgkin's disease, p= 0.03, one tail).
CONCLUSIONS: Some of these findings are confirmatory of previous evidence. Other observations, such as the putative role of the polio virus and of malaria are new. A unifying theory on the mechanisms by which previous medical history may increase the risk of haematolymphopoietic malignancies is still lacking.

Entities:  

Mesh:

Year:  2000        PMID: 10818118      PMCID: PMC1731690          DOI: 10.1136/jech.54.6.431

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  34 in total

1.  Leukemia, lymphoma, and multiple myeloma following selected medical conditions.

Authors:  M M Doody; M S Linet; A G Glass; G D Friedman; L M Pottern; J D Boice; J F Fraumeni
Journal:  Cancer Causes Control       Date:  1992-09       Impact factor: 2.506

2.  Primary hepatosplenic lymphoma: association with hepatitis C virus infection.

Authors:  T Izumi; R Sasaki; Y Miura; H Okamoto
Journal:  Blood       Date:  1996-06-15       Impact factor: 22.113

3.  HCV and non-Hodgkin lymphoma.

Authors:  P Pioltelli; G Zehender; G Monti; A Monteverde; M Galli
Journal:  Lancet       Date:  1996-03-02       Impact factor: 79.321

4.  A prospective study of cancer incidence in a cohort examined for allergy.

Authors:  N E Eriksson; A Holmén; B Högstedt; Z Mikoczy; L Hagmar
Journal:  Allergy       Date:  1995-09       Impact factor: 13.146

5.  Risk of lymphoma in patients with dermatitis herpetiformis.

Authors:  B Sigurgeirsson; B A Agnarsson; B Lindelöf
Journal:  BMJ       Date:  1994-01-01

6.  Hepatitis C virus infection in patients with non-Hodgkin's lymphoma.

Authors:  C Ferri; F Caracciolo; A L Zignego; L La Civita; M Monti; G Longombardo; F Lombardini; F Greco; E Capochiani; A Mazzoni
Journal:  Br J Haematol       Date:  1994-10       Impact factor: 6.998

Review 7.  Epstein-Barr virus and Hodgkin's disease.

Authors:  H Herbst; G Niedobitek
Journal:  Int J Clin Lab Res       Date:  1993

Review 8.  Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis.

Authors:  H Ohshima; H Bartsch
Journal:  Mutat Res       Date:  1994-03-01       Impact factor: 2.433

9.  Incidence of cancer among patients with rheumatoid arthritis.

Authors:  G Gridley; J K McLaughlin; A Ekbom; L Klareskog; H O Adami; D G Hacker; R Hoover; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1993-02-17       Impact factor: 13.506

Review 10.  Malignancy in autoimmune diseases.

Authors:  L J Kinlen
Journal:  J Autoimmun       Date:  1992-04       Impact factor: 7.094

View more
  36 in total

1.  Self-reported history of infections and the risk of non-Hodgkin lymphoma: an InterLymph pooled analysis.

Authors:  Nikolaus Becker; Michael O Falster; Claire M Vajdic; Silvia de Sanjose; Otoniel Martínez-Maza; Paige M Bracci; Mads Melbye; Karin Ekström Smedby; Eric A Engels; Jennifer Turner; Paolo Vineis; Adele Seniori Costantini; Elizabeth A Holly; John J Spinelli; Carlo La Vecchia; Tongzhang Zheng; Brian C-H Chiu; Maurizio Montella; Pierluigi Cocco; Marc Maynadié; Lenka Foretova; Anthony Staines; Paul Brennan; Scott Davis; Richard Severson; James R Cerhan; Elizabeth C Breen; Brenda Birmann; Wendy Cozen; Andrew E Grulich; Robert Newton
Journal:  Int J Cancer       Date:  2012-08-12       Impact factor: 7.396

2.  A prospective study of Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma.

Authors:  Kimberly A Bertrand; Brenda M Birmann; Ellen T Chang; Donna Spiegelman; Jon C Aster; Shumin M Zhang; Francine Laden
Journal:  Blood       Date:  2010-07-20       Impact factor: 22.113

3.  Common immune-related exposures/conditions and risk of non-Hodgkin lymphoma: a case-control study of disease-discordant twin pairs.

Authors:  Jun Wang; Thomas M Mack; Ann S Hamilton; Amie E Hwang; Bharat N Nathwani; Kamil Masood; Laura H Buchanan; Leslie Bernstein; Dennis M Deapen; Otoniel Martínez-Maza; Wendy Cozen
Journal:  Am J Epidemiol       Date:  2015-08-12       Impact factor: 4.897

4.  Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences.

Authors:  Mohamed L Sorror; Sergio Giralt; Brenda M Sandmaier; Marcos De Lima; Munir Shahjahan; David G Maloney; H Joachim Deeg; Frederick R Appelbaum; Barry Storer; Rainer Storb
Journal:  Blood       Date:  2007-09-14       Impact factor: 22.113

Review 5.  Atopy and Specific Cancer Sites: a Review of Epidemiological Studies.

Authors:  Yubao Cui; Andrew W Hill
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

6.  Infectious, autoimmune and allergic diseases and risk of Hodgkin lymphoma in children and adolescents: a Children's Oncology Group study.

Authors:  Amy M Linabery; Erik B Erhardt; Rachel K Fonstad; Richard F Ambinder; Greta R Bunin; Julie A Ross; Logan G Spector; Seymour Grufferman
Journal:  Int J Cancer       Date:  2014-03-18       Impact factor: 7.396

7.  Medical history, lifestyle, and occupational risk factors for hairy cell leukemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Authors:  Alain Monnereau; Susan L Slager; Ann Maree Hughes; Alex Smith; Bengt Glimelius; Thomas M Habermann; Sonja I Berndt; Anthony Staines; Aaron D Norman; James R Cerhan; Joshua N Sampson; Lindsay M Morton; Jacqueline Clavel
Journal:  J Natl Cancer Inst Monogr       Date:  2014-08

8.  Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project.

Authors:  Lindsay M Morton; Joshua N Sampson; James R Cerhan; Jennifer J Turner; Claire M Vajdic; Sophia S Wang; Karin E Smedby; Silvia de Sanjosé; Alain Monnereau; Yolanda Benavente; Paige M Bracci; Brian C H Chiu; Christine F Skibola; Yawei Zhang; Sam M Mbulaiteye; Michael Spriggs; Dennis Robinson; Aaron D Norman; Eleanor V Kane; John J Spinelli; Jennifer L Kelly; Carlo La Vecchia; Luigino Dal Maso; Marc Maynadié; Marshall E Kadin; Pierluigi Cocco; Adele Seniori Costantini; Christina A Clarke; Eve Roman; Lucia Miligi; Joanne S Colt; Sonja I Berndt; Andrea Mannetje; Anneclaire J de Roos; Anne Kricker; Alexandra Nieters; Silvia Franceschi; Mads Melbye; Paolo Boffetta; Jacqueline Clavel; Martha S Linet; Dennis D Weisenburger; Susan L Slager
Journal:  J Natl Cancer Inst Monogr       Date:  2014-08

9.  Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders.

Authors:  Linda Morris Brown; Gloria Gridley; David Check; Ola Landgren
Journal:  Blood       Date:  2008-01-31       Impact factor: 22.113

10.  Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis.

Authors:  Claire M Vajdic; Michael O Falster; Silvia de Sanjose; Otoniel Martínez-Maza; Nikolaus Becker; Paige M Bracci; Mads Melbye; Karin Ekström Smedby; Eric A Engels; Jennifer Turner; Paolo Vineis; Adele Seniori Costantini; Elizabeth A Holly; Eleanor Kane; John J Spinelli; Carlo La Vecchia; Tongzhang Zheng; Brian C-H Chiu; Luigino Dal Maso; Pierluigi Cocco; Marc Maynadié; Lenka Foretova; Anthony Staines; Paul Brennan; Scott Davis; Richard Severson; James R Cerhan; Elizabeth C Breen; Brenda Birmann; Wendy Cozen; Andrew E Grulich
Journal:  Cancer Res       Date:  2009-08-04       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.